Clinical Trial Update: The Effect of Fluvastatin XL® Treatment in Patients With Metabolic Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating Fluvastatin XL in metabolic syndrome has completed, with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Syndrome

Drugs mentioned

• Fluvastatin XL (fluvastatin)

Snippet

Sponsor: Novartis | Conditions: Metabolic Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2011-05-17